Dynamics of spread of Salmonella enterica in the systemic compartment

Microbes and Infection

Volumn 15, Issue 13, 2013, Pages 849-857

  Mastroeni, Pietro ^a   Grant, Andrew ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Immunity; Infection; Salmonella; Spread; Type 3 secretion systems

Indexed keywords

CATALASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; OXYGEN RADICAL; PEROXIREDOXIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; WATER;

BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIOSTASIS; BACTERIUM CONTAMINATION; BACTERIUM MUTANT; CYTOKINE RELEASE; DISEASE COURSE; ENTEROCOLITIS; ENZYME SUBSTRATE COMPLEX; FOOD CONTAMINATION; GASTROENTERITIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; INTRACELLULAR KILLING; INTRACELLULAR SPACE; MACROPHAGE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOGENICITY ISLAND; PERSISTENT INFECTION; PHAGOCYTE; PRIORITY JOURNAL; REGULON; SALMONELLA; SALMONELLA PATHOGENICITY ISLAND 1; SALMONELLOSIS; SHORT SURVEY; TYPE III SECRETION SYSTEM; WATER CONTAMINATION;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA;

IMMUNITY; INFECTION; SALMONELLA; SPREAD; TYPE 3 SECRETION SYSTEMS;

ANIMALS; BACTERIAL PROTEINS; CARDIOVASCULAR SYSTEM; HUMANS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; VIRULENCE FACTORS;

EID: 84888044811     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.10.003     Document Type: Short Survey

References (80)

1. Patel J.C., Galan J.E. Manipulation of the host actin cytoskeleton by Salmonella - all in the name of entry. Curr. Opin. Microbiol. 2005, 8:10-15.
2. Haraga A., Ohlson M.B., Miller S.I. Salmonellae interplay with host cells. Nat. Rev. Microbiol. 2008, 6:53-66.
3. Santos R.L., Raffatellu M., Bevins C.L., Adams L.G., Tukel C., Tsolis R.M., Baumler A.J. Life in the inflamed intestine, Salmonella style. Trends Microbiol. 2009, 17:498-506.
4. Feasey N.A., Dougan G., Kingsley R.A., Heyderman R.S., Gordon M.A. Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 2012, 379:2489-2499.
5. Gordon M.A. Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr. Opin. Infect Dis. 2011, 24:484-489.
6. Wangdi T., Winter S.E., Baumler A.J. Typhoid fever: "you can't hit what you can't see". Gut Microbes 2012, 3:88-92.
7. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2:361-367.
8. Vazquez-Torres A., Jones-Carson J., Baumler A.J., Falkow S., Valdivia R., Brown W., Le M., Berggren R., Parks W.T., Fang F.C. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 1999, 401:804-808.
9. Carter P.B., Collins F.M. The route of enteric infection in normal mice. J. Exp. Med. 1974, 139:1189-1203.
10. Garvis S.G., Beuzon C.R., Holden D.W. A role for the PhoP/Q regulon in inhibition of fusion between lysosomes and Salmonella-containing vacuoles in macrophages. Cell Microbiol. 2001, 3:731-744.
11. Biozzi G., Howard J.G., Halpern B.N., Stiffel C., Mouton D. The kinetics of blood clearance of isotopically labelled Salmonella enteritidis by the reticuloendothelial system in mice. Immunology 1960, 3:74-89.
12. Warren J., Mastroeni P., Dougan G., Noursadeghi M., Cohen J., Walport M.J., Botto M. Increased susceptibility of C1q-deficient mice to Salmonella enterica serovar Typhimurium infection. Infect Immun. 2002, 70:551-557.
13. MacLennan C.A., Gondwe E.N., Msefula C.L., Kingsley R.A., Thomson N.R., White S.A., Goodall M., Pickard D.J., Graham S.M., Dougan G., Hart C.A., Molyneux M.E., Drayson M.T. The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J. Clin. Invest. 2008, 118:1553-1562.
14. Richter-Dahlfors A., Buchan A.M.J., Finlay B.B. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes invivo. J. Exp. Med. 1997, 186:569-580.
15. Sheppard M., Webb C., Heath F., Mallows V., Emilianus R., Maskell D., Mastroeni P. Dynamics of bacterial growth and distribution within the liver during Salmonella infection. Cell Microbiol. 2003, 5:593-600.
16. Nakoneczna I., Hsu H.S. The comparative histopathology of primary and secondary lesions in murine salmonellosis. Br. J. Exp. Pathol. 1980, 61:76-84.
17. Everest P., Roberts M., Dougan G. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect Immun. 1998, 66:3355-3364.
18. Mastroeni P., Arena A., Costa G.B., Liberto M.C., Bonina L., Hormaeche C.E. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb. Pathog. 1991, 11:33-38.
19. Mastroeni P., Skepper J.N., Hormaeche C.E. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections (published erratum appears in Infect Immun 1995 Dec;63(12):4966). Infect Immun. 1995, 63:3674-3682.
20. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Microb. Pathog. 1993, 14:473-480.
21. Mastroeni P., Clare S., Khan S., Harrison J.A., Hormaeche C.E., Okamura H., Kurimoto M., Dougan G. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun. 1999, 67:478-483.
22. Mastroeni P., Harrison J.A., Chabalgoity J.A., Hormaeche C.E. Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect Immun. 1996, 64:189-196.
23. Mastroeni P., Harrison J.A., Robinson J.H., Clare S., Khan S., Maskell D.J., Dougan G., Hormaeche C.E. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun. 1998, 66:4767-4776.
24. Mastroeni P., Villarreal-Ramos B., Hormaeche C.E. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Microb. Pathog. 1992, 13:477-491.
25. Muotiala A., Makela P.H. The role of IFN-gamma in murine Salmonella typhimurium infection. Microb. Pathog. 1990, 8:135-141.
26. Nauciel C., Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun. 1992, 60:450-454.
27. Vazquez-Torres A., Jones-Carson J., Mastroeni P., Ischiropoulos H., Fang F.C. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages invitro. J. Exp. Med. 2000, 192:227-236.
28. Blackwell J.M., Goswami T., Evans C.A., Sibthorpe D., Papo N., White J.K., Searle S., Miller E.N., Peacock C.S., Mohammed H., Ibrahim M. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 2001, 3:773-784.
29. White J.K., Mastroeni P., Popoff J.F., Evans C.A., Blackwell J.M. Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity. J. Leukocyte Biol. 2005, 77:311-320.
30. Hormaeche C.E. Genetics of natural resistance to salmonellae in mice. Immunology 1979, 37:319-327.
31. Hormaeche C.E. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 1979, 37:311-318.
32. Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993, 73:469-485.
33. Buchmeier N.A., Heffron F. Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium. Infect Immun. 1991, 59:2232-2238.
34. Hormaeche C.E. The natural resistance of radiation chimeras to S. typhimurium C5. Immunology 1979, 37:329-332.
35. Dunlap N.E., Benjamin W.H., McCall R.D., Tilden A.B., Briles D.E. A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice. Microb. Pathog. 1991, 10:297-310.
36. Dunlap N.E., Benjamin W.H., Berry A.K., Eldridge J.H., Briles D.E. A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells. Microb. Pathog. 1992, 13:181-190.
37. Geddes K., Cruz F., Heffron F. Analysis of cells targeted by Salmonella type III secretion invivo. PLoS Pathog. 2007, 3:e196.
38. Hsu H.S. Pathogenesis and immunity in murine salmonellosis. Microbiol. Rev. 1989, 53:390-409.
39. Yrlid U., Svensson M., Hakansson A., Chambers B.J., Ljunggren H.G., Wick M.J. Invivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect Immun. 2001, 69:5726-5735.
40. Menendez A., Arena E.T., Guttman J.A., Thorson L., Vallance B.A., Vogl W., Finlay B.B. Salmonella infection of gallbladder epithelial cells drives local inflammation and injury in a model of acute typhoid fever. J. Infect Dis. 2009, 200:1703-1713.
41. Crawford R.W., Rosales-Reyes R., Ramirez-Aguilar Mde L., Chapa-Azuela O., Alpuche-Aranda C., Gunn J.S. Gallstones play a significant role in Salmonellaspp. gallbladder colonization and carriage. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:4353-4358.
42. Salcedo S.P., Noursadeghi M., Cohen J., Holden D.W. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages invivo. Cell Microbiol. 2001, 3:587-597.
43. Andrews-Polymenis H.L., Baumler A.J., McCormick B.A., Fang F.C. Taming the elephant: Salmonella biology, pathogenesis, and prevention. Infect Immun. 2010, 78:2356-2369.
44. Fang F.C. Antimicrobial actions of reactive oxygen species. MBio 2011, 2:e00141.
45. Chakravortty D., Hansen-Wester I., Hensel M. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 2002, 195:1155-1166.
46. Vazquez-Torres A., Xu Y., Jones-Carson J., Holden D.W., Lucia S.M., Dinauer M.C., Mastroeni P., Fang F.C. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 2000, 287:1655-1658.
47. Gallois A., Klein J.R., Allen L.A., Jones B.D., Nauseef W.M. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 2001, 166:5741-5748.
48. Suvarnapunya A.E., Stein M.A. DNA base excision repair potentiates the protective effect of Salmonella Pathogenicity Island 2 within macrophages. Microbiology 2005, 151:557-567.
49. De Groote M.A., Ochsner U.A., Shiloh M.U., Nathan C., McCord J.M., Dinauer M.C., Libby S.J., Vazquez-Torres A., Xu Y., Fang F.C. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13997-14001.
50. Aussel L., Zhao W., Hebrard M., Guilhon A.A., Viala J.P., Henri S., Chasson L., Gorvel J.P., Barras F., Meresse S. Salmonella detoxifying enzymes are sufficient to cope with the host oxidative burst. Mol. Microbiol. 2011, 80:628-640.
51. Hebrard M., Viala J.P., Meresse S., Barras F., Aussel L. Redundant hydrogen peroxide scavengers contribute to Salmonella virulence and oxidative stress resistance. J. Bacteriol. 2009, 191:4605-4614.
52. Fang F.C., DeGroote M.A., Foster J.W., Baumler A.J., Ochsner U., Testerman T., Bearson S., Giard J.C., Xu Y., Campbell G., Laessig T. Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7502-7507.
53. Groisman E.A., Parra-Lopez C., Salcedo M., Lipps C.J., Heffron F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11939-11943.
54. Halsey T.A., Vazquez-Torres A., Gravdahl D.J., Fang F.C., Libby S.J. The ferritin-like Dps protein is required for Salmonella enterica serovar Typhimurium oxidative stress resistance and virulence. Infect Immun. 2004, 72:1155-1158.
55. Wright J.A., Totemeyer S.S., Hautefort I., Appia-Ayme C., Alston M., Danino V., Paterson G.K., Mastroeni P., Menager N., Rolfe M., Thompson A., Ugrinovic S., Sait L., Humphrey T., Northen H., Peters S.E., Maskell D.J., Hinton J.C., Bryant C.E. Multiple redundant stress resistance mechanisms are induced in Salmonella enterica serovar Typhimurium in response to alteration of the intracellular environment via TLR4 signalling. Microbiology 2009, 155:2919-2929.
56. Faucher S.P., Porwollik S., Dozois C.M., McClelland M., Daigle F. Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1906-1911.
57. Mastroeni P., Morgan F.J., McKinley T.J., Shawcroft E., Clare S., Maskell D.J., Grant A.J. Enhanced virulence of Salmonella enterica serovar Typhimurium after passage through mice. Infect Immun. 2011, 79:636-643.
58. Grant A.J., Foster G.L., McKinley T.J., Brown S.P., Clare S., Maskell D.J., Mastroeni P. Bacterial growth rate and host factors as determinants of intracellular bacterial distributions in systemic Salmonella enterica infections. Infect Immun. 2009, 77:5608-5611.
59. Grant A.J., Morgan F.J., McKinley T.J., Foster G.L., Maskell D.J., Mastroeni P. Attenuated Salmonella Typhimurium lacking the pathogenicity island-2 type 3 secretion system grow to high bacterial numbers inside phagocytes in mice. PLoS Pathog. 2012, 8:e1003070.
60. Grant A.J., Sheppard M., Deardon R., Brown S.P., Foster G., Bryant C.E., Maskell D.J., Mastroeni P. Caspase-3-dependent phagocyte death during systemic Salmonella enterica serovar Typhimurium infection of mice. Immunology 2008, 125:28-37.
61. Janis C., Grant A.J., McKinley T.J., Morgan F.J., John V.F., Houghton J., Kingsley R.A., Dougan G., Mastroeni P. Invivo regulation of the Vi antigen in Salmonella and induction of immune responses with an invivo-inducible promoter. Infect Immun. 2011, 79:2481-2488.
62. Brown S.P., Cornell S.J., Sheppard M., Grant A.J., Maskell D.J., Grenfell B.T., Mastroeni P. Intracellular demography and the dynamics of Salmonella enterica infections. PLoS Biol. 2006, 4:e349.
63. Helaine S., Holden D.W. Heterogeneity of intracellular replication of bacterial pathogens. Curr. Opin. Microbiol. 2013, 16:184-191.
64. Helaine S., Thompson J.A., Watson K.G., Liu M., Boyle C., Holden D.W. Dynamics of intracellular bacterial replication at the single cell level. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3746-3751.
65. Fink S.L., Cookson B.T. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol. 2007, 9:2562-2570.
66. Cirillo D.M., Valdivia R.H., Monack D.M., Falkow S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 1998, 30:175-188.
67. Hensel M., Shea J.E., Waterman S.R., Mundy R., Nikolaus T., Banks G., Vazquez-Torres A., Gleeson C., Fang F.C., Holden D.W. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 1998, 30:163-174.
68. Ochman H., Soncini F.C., Solomon F., Groisman E.A. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7800-7804.
69. Khan S.A., Stratford R., Wu T., McKelvie N., Bellaby T., Hindle Z., Sinha K.A., Eltze S., Mastroeni P., Pickard D., Dougan G., Chatfield S.N., Brennan F.R. Salmonella typhi and S. typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors. Vaccine 2003, 21:538-548.
70. Figueira R., Holden D.W. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology 2012, 158:1147-1161.
71. Figueira R., Watson K.G., Holden D.W., Helaine S. Identification of Salmonella pathogenicity island-2 type III secretion system effectors involved in intramacrophage replication of S. enterica serovar Typhimurium: implications for rational vaccine design. mBio 2013, 4:e00065.
72. Hensel M., Shea J.E., Gleeson C., Jones M.D., Dalton E., Holden D.W. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995, 269:400-403.
73. Forest C.G., Ferraro E., Sabbagh S.C., Daigle F. Intracellular survival of Salmonella enterica serovar Typhi in human macrophages is independent of Salmonella pathogenicity island (SPI)-2. Microbiology 2010, 156:3689-3698.
74. Rytkonen A., Poh J., Garmendia J., Boyle C., Thompson A., Liu M., Freemont P., Hinton J.C., Holden D.W. SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:3502-3507.
75. Libby S.J., Lesnick M., Hasegawa P., Weidenhammer E., Guiney D.G. The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages. Cell Microbiol. 2000, 2:49-58.
76. Guiney D.G., Fierer J. The role of the spv genes in Salmonella pathogenesis. Front Microbiol. 2011, 2:129.
77. Tran T.H., Nguyen T.D., Nguyen T.T., Ninh T.T., Tran N.B., Nguyen V.M., Tran T.T., Cao T.T., Pham V.M., Nguyen T.C., Tran T.D., Pham V.T., To S.D., Campbell J.I., Stockwell E., Schultsz C., Simmons C.P., Glover C., Lam W., Marques F., May J.P., Upton A., Budhram R., Dougan G., Farrar J., Nguyen V.V., Dolecek C. A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children. PLoS One 2010, 5:e11778.
78. Mastroeni P., Vazquez-Torres A., Fang F.C., Xu Y., Khan S., Hormaeche C.E., Dougan G. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival invivo. J. Exp. Med. 2000, 192:237-248.
79. Vazquez-Torres A., Fantuzzi G., Edwards C.K., Dinarello C.A., Fang F.C. Defective localization of the NADPH phagocyte oxidase to Salmonella- containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2561-2565.
80. Grant A.J., Restif O., McKinley T.J., Sheppard M., Maskell D.J., Mastroeni P. Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLoS Biol. 2008, 6:e74.